Page last updated: 2024-11-03

risperidone and Congenital Adrenal Hyperplasia

risperidone has been researched along with Congenital Adrenal Hyperplasia in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrillo de Albornoz, CM1
Guerrero-Jimenez, M1
Gutierrez-Rojas, L1

Other Studies

1 other study available for risperidone and Congenital Adrenal Hyperplasia

ArticleYear
[Antypsychotic-induced central pontine myelinolysis in a congenital adrenal hyperplasia subject].
    Revista de neurologia, 2017, 03-01, Volume: 64, Issue:5

    Topics: Adrenal Hyperplasia, Congenital; Adult; Antipsychotic Agents; Humans; Male; Myelinolysis, Central Po

2017